Ophthalmic Business News

In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo discuss the latest news in eye care and chat with Wiley A. Chambers, MD, about his career in the FDA and his plans for retirement.

MCO-010 demonstrated positive topline results in vision improvement in patients with permanent and severe vision loss from advanced retinitis pigmentosa, according to a press release from Nanoscope Therapeutics.

Terry Kim, MD, is joining Alcon as chief medical officer and head of global medical safety, according to a press release.

Patients with neovascular age-related macular degeneration experienced visual benefits and anatomic improvements with extended dosing intervals of IBI302, according to a press release from Innovent Biologics.

When she started a career in medicine, Emily M. Schehlein, MD, wanted to make an impact.

OcuTerra Therapeutics is evaluating strategic alternatives after the phase 2 DR:EAM trial failed to meet its primary efficacy endpoint, according to a press release.

Healio | OSN Chief Medical Editor Richard L. Lindstrom, MD, a leader in corneal, cataract, refractive and laser surgery, has been appointed as founder and chairman of Surface Ophthalmics, according to a press release.

Completing medical education and training is a monumental achievement that can launch a successful lifetime career.

In this episode, Dagny Zhu, MD, talks diversity in leadership with Lori Tierney, as well as her journey from vision science to president of Americas for Johnson & Johnson Vision.

Tarsus Pharmaceuticals has launched a campaign for Xdemvy to raise consumer awareness about Demodex blepharitis, according to a press release.